Steroid-Free Immunosuppression After Liver Transplantation Does Not Increase the Risk of Graft Fibrosis

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1237-1239

  Manzia, T M ^a   Toti, L ^a   Angelico, R ^a   Di Cocco, P ^b   Orlando, G ^b   Tisone, G ^b  

^a Surgical Clinic   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CHOLESTEROL; CREATININE; CYCLOSPORIN A; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; TRIACYLGLYCEROL;

ACUTE GRAFT REJECTION; ACUTE HEART FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER FIBROSIS; LIVER FUNCTION; LIVER GRAFT; LIVER GRAFT FIBROSIS; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LUNG CARCINOMA; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETRANSPLANTATION; RISK ASSESSMENT; TONGUE CARCINOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENAL CORTEX HORMONES; ADULT; ALANINE TRANSAMINASE; AZATHIOPRINE; BILIRUBIN; CREATININE; CYCLOSPORINE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SAFETY; SURVIVAL RATE; SURVIVORS; TIME FACTORS;

EID: 77952604532     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.118     Document Type: Article

References (9)

1. Lake J.R., Roberts J.P., and Asher N.L. Maintenance immunosuppression after liver transplantation. Semin Liver Dis 12 (1992) 73
2. Klintmalm G.B., Nery J.R., Husberg B.S., et al. Rejection after liver transplantation. Hepatology 10 (1989) 978
3. Stegall M.D., Everson G., Schorter G., et al. Metabolic complication after liver transplantation: diabetes, hypercholesterolemia, hypertension and obesity. Transplantation 60 (1995) 1057
4. Tisone G., Angelico M., Palmieri G., et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation 67 (1999) 1308
5. Tisone G., Angelico M., Palmieri G., et al. Immunosuppression without prednisone after liver transplantation is safe and associated with normal early graft function: preliminary results of a randomized study. Transpl Int 11 suppl 1 (1998) S267
6. Tisone G., Angelico M., Orlando G., et al. Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids. Transplant Proc 31 (1999) 2908
7. Evans H.M., Mckiernan P.J., Beath S.V., et al. Histology of liver allografts five years following pediatric liver transplantation. Hepatology 32 (2000) 227A
8. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696
9. Tisone G., Orlando G., Cardillo A., et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol 44 (2006) 702